Stocktoria
Cocrystal Pharma, Inc. COCP
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2018-03-12
Cocrystal Pharma, Inc. statistics & valuation
Market cap$14.1M
P / B2.2×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Return on assets | -90.9% | -130.1% | -57.5% | -95.1% | -17.9% |
| Return on equity | -139.5% | -183.8% | -68.2% | -98.1% | -18.3% |
| Current ratio | 3.68 | 4.77 | 8.92 | 33.04 | 38.40 |
Source: SEC EDGAR filings · CIK 0001412486 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.